Lupin Ltd.

NSE: LUPIN | BSE: 500257

Mid-range Performer

In 2 Starfolio Baskets

Download real time

2267.70 17.90 (0.80%)

1.1M

NSE+BSE Volume

NSE 05 Jun, 2026 3:31 PM (IST)

US FDA Approval

Lupin gets US FDA nod for ranibizumab injection for eye diseases, with a market size of $2.9 bn See details

Lupin quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents